190 related articles for article (PubMed ID: 24640678)
1. [Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
Duma SN
Ter Arkh; 2013; 85(12):100-5. PubMed ID: 24640678
[TBL] [Abstract][Full Text] [Related]
2. [Neurometabolic therapy of mild cognitive impairment in patients with chronic cerebral ischemia].
Antipenko EA; Shulyndin AV; Belyakov KM
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(3):42-51. PubMed ID: 38529862
[TBL] [Abstract][Full Text] [Related]
3. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
Abramenko IuV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of asthenic syndrome in elderly people after acute respiratory viral infection].
Poverennova IE; Zolotovskaia IA; Bezgina EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):73-6. PubMed ID: 25403306
[TBL] [Abstract][Full Text] [Related]
5. [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
Fedin AI; Zakharov VV; Tanashyan MM; Chukanova EI; Madzhidova EN; Shchepankevich LA; Ostroumova OD
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):7-16. PubMed ID: 34932280
[TBL] [Abstract][Full Text] [Related]
6. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
Kutashov VA; Ulyanova OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral ischemia].
Shchepankevich LA; Nikolaev YA; Taneeva EV; Pervuninskaya MA; Shchepankevich MS
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10):32-37. PubMed ID: 34874652
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic effects of mexidol in complex treatment of chronic brain ischemia].
Demchenko EIu; Kulakova NV; Semiglazova TA; Golovacheva AB; Borodulina EV; Udut VV
Eksp Klin Farmakol; 2008; 71(6):13-5. PubMed ID: 19140508
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of asthenic syndrome in patients with chronic brain ischemia: results of the non-interventional observational program TRIUMPH].
Fedin AI; Solov'eva ÉI; Mironova OP; Fedotova AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):104-111. PubMed ID: 25726789
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the international multicenter, randomized, double-blind, placebo-controlled study of sequential therapy in patients with chronic brain ischemia MEMO)].
Zakharov VV; Tkacheva ON; Mkhitaryan EA; Fedin AI
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):73-80. PubMed ID: 36412160
[TBL] [Abstract][Full Text] [Related]
11. [Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis].
Vizilo TL; Arefieva EG
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):51-55. PubMed ID: 36946397
[TBL] [Abstract][Full Text] [Related]
12. [The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia].
Chukanova EI; Chukanova AS; Mamayeva KI
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):71-74. PubMed ID: 26081329
[TBL] [Abstract][Full Text] [Related]
13. [Asthenic disorders and cognitive dysfunction in patients with tension headache].
Chutko LS; Surushkina SIu; Rozhkova AV; Iakovenko EA; Bykova IuL; Nikishina IS
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):31-5. PubMed ID: 23739500
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of alpha-lipoic acid and mexidol effects on affective status, cognitive functions and quality of life in diabetes mellitus patients].
Volchegorskiĭ IA; Rassokhina LM; Koliadich MI; Alekseev MI
Eksp Klin Farmakol; 2011; 74(11):17-23. PubMed ID: 22288155
[TBL] [Abstract][Full Text] [Related]
15. [Results of multicenter study of efficacy and safety of divaza in the treatment of the asthenic and mild to moderate cognitive disorders in elderly and senile subjects].
Parfenov VА; Kamchatnov PR; Vorobyova ОV; Gustov АV; Glushkov КS; Doronina ОB
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):43-50. PubMed ID: 29053120
[TBL] [Abstract][Full Text] [Related]
16. [Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
Abramenko YV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):59-64. PubMed ID: 32307432
[TBL] [Abstract][Full Text] [Related]
17. [Effect of mexidol on oxidative stress in cerebral variant of hypertensive crisis].
Golikov AP; Golikov PP; Davydov BV; Riabinin VA; Luk'ianov MM; Kalinin AN; Klychnikova EV; Promanenkov VK
Kardiologiia; 2002; 42(3):25-9. PubMed ID: 12494182
[TBL] [Abstract][Full Text] [Related]
18. [Adaptogenic effects of mexidol in chronic cerebral ischemia].
Antipenko EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):44-9. PubMed ID: 22677755
[TBL] [Abstract][Full Text] [Related]
19. [Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19].
Kovalchuk VV; Ershova II; Molodovskaya NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):60-66. PubMed ID: 33908234
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
Strelnikova IA; Svetkina AA; Androfagina OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):54-58. PubMed ID: 32307431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
